The monoclonal antibody is directed against the HLA-DR-antigen of human B lymphocytes The antibody reacts with the cells of the monocytic lineage, with myeloblasts and promyelocytes and the cells of B lymphocyte lineage. Polymorphonuclear leukocytes and platelets are found negative.

Target	HLA-DR
Reactivity	Human
Host	Mouse
Clonality	Monoclonal
Tested Applications	FCM
Recommended dilutions	FCM: 20 μl/1 million cells. Optimal dilutions/concentrations should be determined by the end user.
Immunogen	Mononuclear cell leukemia acute undifferentiated.
Purification	Affinity Chromatography
Form	Liquid
Isotype	IgG2a
Conjugation	PerCP-Cy5.5
Specificity	B cells lymphocytes, Haemopoietic precursor cells, activated T-cells, monocytic cells and macrophages. This monoclonal antibody is validated in Nalm-6 cell line
Storage	Store in the dark at 2-8 °C.
Molecular Weight	36 kDa
Swiss Prot	P04233
GeneID	3122
Buffer	The reagent is provided in aqueous buffered solution containing protein stabilizer, and ≤0.09% sodium Azide
Availability	Shipped within 2-3 weeks.
Note	This product is for research use only.